These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8330033)

  • 1. A simple severity of disease index for systemic lupus erythematosus.
    Katz JD; Senecal JL; Rivest C; Goulet JR; Rothfield N
    Lupus; 1993 Apr; 2(2):119-23. PubMed ID: 8330033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
    Becker-Merok A; Nossent HC
    J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus disease severity in men and women: a case-control study.
    Aranow C; Del Guidice J; Barland P; Weinstein A
    J Rheumatol; 2002 Aug; 29(8):1674-7. PubMed ID: 12180728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
    Griffiths B; Mosca M; Gordon C
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus.
    Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
    J Rheumatol; 1997 Feb; 24(2):309-13. PubMed ID: 9034988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices.
    Guzmán J; Cardiel MH; Arce-Salinas A; Sánchez-Guerrero J; Alarcón-Segovia D
    J Rheumatol; 1992 Oct; 19(10):1551-8. PubMed ID: 1464867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for neuropsychiatric manifestations in children with systemic lupus erythematosus: case-control study.
    Zuniga Zambrano YC; Guevara Ramos JD; Penagos Vargas NE; Benitez Ramirez DC; Ramirez Rodriguez SM; Vargas Niño AC; Izquierdo Bello AH
    Pediatr Neurol; 2014 Sep; 51(3):403-9. PubMed ID: 25160546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
    Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
    J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
    Brunner HI; Feldman BM; Bombardier C; Silverman ED
    Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus disease activity index 2000.
    Gladman DD; Ibañez D; Urowitz MB
    J Rheumatol; 2002 Feb; 29(2):288-91. PubMed ID: 11838846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and evaluation of the German Brief Index of Lupus Damage (BILD)--a self-reported instrument to record damage in systemic lupus erythematosus.
    Chehab G; Sander O; Richter J; Acar H; Vordenbäumen S; Brinks R; Schneider M; Fischer-Betz R
    Lupus; 2013 Sep; 22(10):1050-5. PubMed ID: 23963433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frequency, clinical implication and prognostic value of lymphopenia in systemic lupus erythematosus: case-control study].
    Ha-ou-nou FZ; Essaadouni L
    Pan Afr Med J; 2015; 21():3. PubMed ID: 26401197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity.
    Yee CS; Farewell V; Isenberg DA; Prabu A; Sokoll K; Teh LS; Rahman A; Bruce IN; Griffiths B; Akil M; McHugh N; D'Cruz D; Khamashta MA; Bowman S; Maddison P; Zoma A; Allen E; Gordon C;
    Arthritis Rheum; 2006 Oct; 54(10):3300-5. PubMed ID: 17009266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C).
    García-Carrasco M; Mendoza-Pinto C; Cardiel MH; Méndez-Martínez S; García-Villaseñor A; Jiménez-Hernández C; Alonso-García NE; Briones-Rojas R; Ramos-Álvarez G; López-Colombo A
    Lupus; 2012 Oct; 21(11):1219-24. PubMed ID: 22875651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity criteria in systemic lupus erythematosus.
    Bombardieri S; Vitali C; Caponi L; Manca L; Bencivelli W
    Clin Exp Rheumatol; 1994; 12 Suppl 11():S45-8. PubMed ID: 7768051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB; Bae SC
    Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.